[go: up one dir, main page]

UA41252C2 - Похідні та аналоги 2-дезокси-2,3-дидегідро-n-ацетилнеурамінової кислоти, спосіб їх одержання, фармацевтична композиція, спосіб лікування вірусних інфекцій - Google Patents

Похідні та аналоги 2-дезокси-2,3-дидегідро-n-ацетилнеурамінової кислоти, спосіб їх одержання, фармацевтична композиція, спосіб лікування вірусних інфекцій

Info

Publication number
UA41252C2
UA41252C2 UA92016283A UA92016283A UA41252C2 UA 41252 C2 UA41252 C2 UA 41252C2 UA 92016283 A UA92016283 A UA 92016283A UA 92016283 A UA92016283 A UA 92016283A UA 41252 C2 UA41252 C2 UA 41252C2
Authority
UA
Ukraine
Prior art keywords
self
exercises
musculoskeletal system
composition
elements
Prior art date
Application number
UA92016283A
Other languages
English (en)
Inventor
Лоренс Марк фон Іцштейн
Вен-Янг Ву
То Ван Фан
Базіль Данілек
Бетті Джін
Original Assignee
Біота Сайнтіфік Менеджмент Пті, Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Біота Сайнтіфік Менеджмент Пті, Лтд filed Critical Біота Сайнтіфік Менеджмент Пті, Лтд
Publication of UA41252C2 publication Critical patent/UA41252C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Винахід відноситься до медицини, зокрема неврології, ортопедії, психофізичної реабілітації. Спосіб здійснюється шляхом виконання набору вправ, який підбирають індивідуально під час сеансів мануальної терапії у відповідності із станом опорно-рухового апарату і змінюють цей набір відповідно до ступеня відновлення рухового стереотипу і рівноважного стану кістково-м'язового апарата в післялікувальний період, причому під час лікування вправи виконують за допомогою оператора, в післялікувальний період - під контролем оператора, а потім самостійно. Вправи в наборі містять елементи самомануальної терапії, елементи відпочинку, а також підготовчі елементи перед навантаженням і узгоджуються з диханням — вдих при максимальному навантаженні. При виконанні вправ застосовують прийоми самомануальної терапії, які збільшують навантаження до максимально можливої межі для даної людини і які сприяють направленій дії на частини і ділянки тіла з придбаними патологіями: самообертання, самофіксація, самонатискання, саморозгинання, самозгинання. Вправи узгоджують з диханням — вдих при максимальному навантаженні. Технічний результат: забезпечується поетапно, щадне відновлення рухового стереотипу з урахуванням індивідуальності хворого, стану його опорно-рухового апарата.
UA92016283A 1990-04-24 1991-04-24 Похідні та аналоги 2-дезокси-2,3-дидегідро-n-ацетилнеурамінової кислоти, спосіб їх одержання, фармацевтична композиція, спосіб лікування вірусних інфекцій UA41252C2 (uk)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPJ980090 1990-04-24
AUPK289690 1990-10-19
AUPK453791 1991-02-11
PCT/AU1991/000161 WO1991016320A1 (en) 1990-04-24 1991-04-24 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents

Publications (1)

Publication Number Publication Date
UA41252C2 true UA41252C2 (uk) 2001-09-17

Family

ID=27157556

Family Applications (1)

Application Number Title Priority Date Filing Date
UA92016283A UA41252C2 (uk) 1990-04-24 1991-04-24 Похідні та аналоги 2-дезокси-2,3-дидегідро-n-ацетилнеурамінової кислоти, спосіб їх одержання, фармацевтична композиція, спосіб лікування вірусних інфекцій

Country Status (37)

Country Link
US (2) US5360817A (uk)
EP (2) EP0786458B1 (uk)
JP (1) JP2944750B2 (uk)
KR (1) KR0169496B1 (uk)
CN (3) CN1143853C (uk)
AP (1) AP249A (uk)
AT (2) ATE161253T1 (uk)
AU (2) AU654815B2 (uk)
BG (1) BG62092B1 (uk)
CA (2) CA2081356C (uk)
CY (1) CY2186B1 (uk)
CZ (1) CZ288492B6 (uk)
DE (3) DE69133604D1 (uk)
DK (1) DK0526543T3 (uk)
ES (2) ES2113881T3 (uk)
FI (2) FI105478B (uk)
GR (1) GR3026225T3 (uk)
HK (2) HK1003834A1 (uk)
HU (2) HU219355B (uk)
IE (2) IE911372A1 (uk)
IL (1) IL97936A (uk)
LU (1) LU90468I2 (uk)
MY (1) MY107843A (uk)
NL (1) NL990030I2 (uk)
NO (3) NO302751B1 (uk)
NZ (1) NZ237936A (uk)
OA (1) OA09679A (uk)
PL (3) PL167630B1 (uk)
PT (1) PT97460B (uk)
RU (1) RU2119487C1 (uk)
SG (1) SG43170A1 (uk)
SI (1) SI9110745B (uk)
SK (1) SK282950B6 (uk)
UA (1) UA41252C2 (uk)
WO (1) WO1991016320A1 (uk)
YU (1) YU48741B (uk)
ZA (1) ZA913086B (uk)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
US5958973A (en) * 1993-09-03 1999-09-28 Gilead Sciences, Inc. Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors
GB9325841D0 (en) 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
EP0711766B1 (en) * 1994-05-27 2000-02-16 Daikin Industries, Limited 7-fluoro-2, 3-didehydrosialic acid and intermediate for synthesis thereof
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
GB9416365D0 (en) * 1994-08-12 1994-10-05 Glaxo Group Ltd Medicaments
US5512596A (en) * 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
US5475109A (en) * 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
AU4259500A (en) * 1995-02-27 2000-08-31 Gilead Sciences, Inc. Novel compounds and methods for synthesis and therapy
AU720933B2 (en) 1995-02-27 2000-06-15 Gilead Sciences, Inc. Novel selective inhibitors of viral or bacterial neuraminidases
CN100338031C (zh) * 1995-02-27 2007-09-19 吉里德科学公司 新颖化合物，其合成方法及治疗用途
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
CA2546660C (en) * 1995-02-27 2009-08-11 Gilead Sciences Inc. Selective inhibitors of viral or bacterial neuraminidase
US5602277A (en) * 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
ATE206116T1 (de) * 1995-05-19 2001-10-15 Biota Scient Management 6-carboxamido-dihydropyran-derivate
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
JPH0967270A (ja) * 1995-08-31 1997-03-11 Res Dev Corp Of Japan 水晶体混濁の予防および治療法、並びにそのための薬 剤
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
ES2197330T3 (es) * 1996-03-01 2004-01-01 Biota Scientific Management Pty. Ltd. Metodo para detectar el virus de gripe y compuestos para emplear en el.
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
DK0823428T3 (da) * 1996-07-22 2002-02-18 Sankyo Co Neuraminsyrederivater, deres fremstilling og deres medicinske anvendelse
CZ293041B6 (cs) * 1996-08-13 2004-01-14 Sankyo Company Limited Sloučeniny kyseliny neuraminové
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
AU711845B2 (en) * 1996-09-10 1999-10-21 Daikin Industries, Ltd. 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds
US5719020A (en) * 1996-09-25 1998-02-17 Oklahoma Medical Research Foundation 4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens
CN1238762A (zh) * 1996-10-21 1999-12-15 吉里德科学公司 哌啶化合物
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
EP0951480A4 (en) * 1996-11-14 2004-07-28 Biota Scient Management METHOD AND NEW CONNECTIONS THAT CAN BE USED IN THIS METHOD.
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
JP3390965B2 (ja) 1997-09-12 2003-03-31 理化学研究所 糖結合スフィンゴシンを含有するポリマー化合物
IL134691A0 (en) * 1997-09-17 2001-04-30 Gilead Sciences Inc Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
US20040053999A1 (en) * 1997-09-17 2004-03-18 Bischofberger Norbert W. Novel compounds and methods for synthesis and therapy
US20030129146A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti The use of bacterial phage associated lysing proteins for treating bacterial dental caries
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
JP2002521312A (ja) * 1998-04-23 2002-07-16 アボット・ラボラトリーズ ノイラミニダーゼの阻害剤
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
KR20010070962A (ko) 1998-07-15 2001-07-28 하싼 요마 유기 인 화합물 및 이의 용도
US6303764B1 (en) 1998-09-24 2001-10-16 Zymetx, Inc. Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminic acids
US6664235B1 (en) 1999-08-20 2003-12-16 Riken Medicaments comprising sialic acid derivatives as active ingredients
US6420552B1 (en) 1999-09-10 2002-07-16 Zymetx, Inc. Syntheses of 4-alkyl chromogenic glycosides and 7-alkyl chromogenic glycosides of N-acetylneuraminic acids
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
WO2001029020A2 (en) * 1999-10-19 2001-04-26 Abbott Laboratories Neuraminidase inhibitors
US6627396B1 (en) 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
EP1263463B1 (en) 2000-03-06 2011-05-25 University of Kentucky Research Foundation Use of an antibody or an immunotoxin that selectively binds to cd123 to impair hematologic cancer progenitor cells
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2003025133A2 (en) * 2001-09-14 2003-03-27 Mimeon, Inc. Methods of making glycolmolecules with enhanced activities and uses thereof
JP2006241024A (ja) * 2005-03-01 2006-09-14 Takashi Suzuki 新規シアル酸誘導体
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
CN100471848C (zh) * 2006-06-05 2009-03-25 中国医学科学院医药生物技术研究所 一组长链烷氧烷基取代唾液酸衍生物及其制备方法
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
JP5345073B2 (ja) 2007-01-23 2013-11-20 テラピコン エス．アール．エル． 抗ウイルス化合物
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US7981930B2 (en) * 2007-03-13 2011-07-19 Adamas Pharmaceuticals, Inc. Compositions and kits for treating influenza
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
CN101681396A (zh) 2007-04-16 2010-03-24 动量制药公司 限定的糖蛋白产品以及相关方法
EP2190439B1 (en) * 2007-08-31 2016-03-09 Academia Sinica Oseltamivir phosphonate derivatives with anti-influenza activity and synthesis thereof
WO2009129305A2 (en) 2008-04-15 2009-10-22 Tsrl, Inc. Prodrugs of neuraminidase inhibitors
ES2442024T3 (es) 2008-07-15 2014-02-07 Academia Sinica Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados
AU2009321347A1 (en) 2008-11-28 2010-06-03 Cipla Limited Process for preparing zanamivir and intermediates for use in the process
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
EP2228054A1 (en) 2009-03-13 2010-09-15 ITALFARMACO S.p.A. Riluzole aqueous suspensions
EP2427446B1 (en) * 2009-05-04 2016-03-30 National Research Council of Canada Inhibitors of sialidase or sialidase-like enzymes
EA201101564A1 (ru) * 2009-05-15 2012-07-30 Редкс Фарма Лимитед Редокс производные лекарственных средств
BR112012001061B8 (pt) 2009-07-15 2021-05-25 Univ British Columbia glicosídeos 2,3-fluorados como inibidores de neuraminidase, seu método de preparação, composição farmacêutica que os compreende e embalagem comercial
WO2011006208A1 (en) * 2009-07-16 2011-01-20 Griffith University Anti -influenza agents
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
JP2011136964A (ja) * 2009-12-28 2011-07-14 Gifu Univ ノイラミン酸誘導体、シアリダーゼ活性阻害剤及び抗インフルエンザ薬
EP2556163B1 (en) 2010-04-07 2016-08-10 Momenta Pharmaceuticals, Inc. Method for quantifying high mannose containing glycoforms
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
EP2975409B1 (en) 2010-05-10 2018-10-31 Academia Sinica Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
CN101921251B (zh) * 2010-09-21 2011-10-05 仙居县圃瑞药业有限公司 扎那米韦中间体的精制工艺方法
CN102464640A (zh) * 2010-10-29 2012-05-23 江苏正大天晴药业股份有限公司 扎那米韦的制备方法
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
WO2012114350A1 (en) 2011-02-24 2012-08-30 Cadila Healthcare Limited Process for the preparation of zanamivir
WO2012125553A2 (en) 2011-03-12 2012-09-20 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing n-glycans in glycoprotein products
WO2012142492A2 (en) * 2011-04-15 2012-10-18 University Of Georgia Research Foundation, Inc. Methods for inhibiting virus replication
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
WO2013093458A2 (en) 2011-12-21 2013-06-27 Redx Pharma Limited Antiviral drug derivatives
US9637465B2 (en) 2012-01-19 2017-05-02 The University Of British Columbia 3′ Equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
US9695244B2 (en) 2012-06-01 2017-07-04 Momenta Pharmaceuticals, Inc. Methods related to denosumab
CA2880701A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
KR102186030B1 (ko) 2012-10-29 2020-12-03 시플라 리미티드 항 바이러스성 포스포네이트 유사체 및 이의 제조를 위한 방법
WO2014149067A1 (en) 2013-03-15 2014-09-25 Momenta Pharmaceuticals, Inc. Methods related to ctla4-fc fusion proteins
EP2996772B1 (en) 2013-05-13 2018-12-19 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
US10086054B2 (en) 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
EP3013347B1 (en) 2013-06-27 2019-12-11 Academia Sinica Glycan conjugates and use thereof
CN103396957B (zh) * 2013-07-11 2015-08-19 中国海洋大学 一种来源于鲤链霉菌的海洋微生物多糖及其制备方法
CN105682666B (zh) 2013-09-06 2021-06-01 中央研究院 使用醣脂激活人类iNKT细胞
CN111018901B (zh) * 2013-09-09 2021-09-03 中国科学院上海有机化学研究所 扎那米韦和拉那米韦的中间体及其合成方法
EP3058084A4 (en) 2013-10-16 2017-07-05 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
WO2015109180A2 (en) 2014-01-16 2015-07-23 Academia Sinica Compositions and methods for treatment and detection of cancers
TWI797430B (zh) 2014-03-27 2023-04-01 中央研究院 反應性標記化合物及其用途
MX2016014859A (es) 2014-05-12 2017-06-27 Glaxosmithkline Intellectual Property (No 2) Ltd Composiciones farmaceuticas que comprenden danirixina para tratar enfermedades infecciosas.
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
WO2015184004A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
CN106661099A (zh) 2014-05-27 2017-05-10 中央研究院 抗her2醣抗体及其用途
TWI654202B (zh) 2014-05-27 2019-03-21 中央研究院 增進抗體功效之通用糖型之組合物及方法
EP3154582A4 (en) 2014-05-28 2018-01-10 Academia Sinica Anti-tnf-alpha glycoantibodies and uses thereof
NL2013420B1 (en) * 2014-09-05 2016-09-27 Univ Griffith Antiviral agents and uses thereof.
TWI745275B (zh) 2014-09-08 2021-11-11 中央研究院 使用醣脂激活人類ｉＮＫＴ細胞
US10328143B2 (en) 2014-10-24 2019-06-25 Peptidream Inc. Hemagglutinin-binding peptide
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
EP3789766A1 (en) 2015-01-24 2021-03-10 Academia Sinica Novel glycan conjugates and methods of use thereof
US10336784B2 (en) 2016-03-08 2019-07-02 Academia Sinica Methods for modular synthesis of N-glycans and arrays thereof
JP7213549B2 (ja) 2016-08-22 2023-01-27 シーエイチオー ファーマ インコーポレイテッド 抗体、結合性断片、および使用の方法
CN106520864A (zh) * 2016-09-28 2017-03-22 南京农业大学 一种酶法合成唾液酸类似物的方法及其应用
EP3630740A4 (en) * 2017-05-25 2021-03-31 The Governors of the University of Alberta METHODS FOR THE PREVENTION OR TREATMENT OF ATHEROSCLEROSIS WITH ISOENZYME INHIBITORS SPECIFIC TO HUMAN NEURAMINIDASE
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
CA3238128A1 (en) 2021-12-23 2023-06-29 Subintro Limited Novel antiviral compositions comprising oleic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE627295A (uk) 1962-01-18

Also Published As

Publication number Publication date
ZA913086B (en) 1992-12-30
DE19975068I1 (de) 2000-01-13
CA2291994A1 (en) 1991-10-25
PL167192B1 (pl) 1995-08-31
NO974670D0 (no) 1997-10-09
MY107843A (en) 1996-06-29
CN1143853C (zh) 2004-03-31
HK1003834A1 (en) 1998-11-06
PT97460A (pt) 1992-01-31
CN1091594C (zh) 2002-10-02
IL97936A (en) 1995-12-08
AU654815B2 (en) 1994-11-24
NO923944L (no) 1992-12-18
GR3026225T3 (en) 1998-05-29
FI924790A0 (fi) 1992-10-22
PT97460B (pt) 1999-01-29
NO923944D0 (no) 1992-10-09
EP0526543A1 (en) 1993-02-10
US5360817A (en) 1994-11-01
BG96978A (bg) 1993-12-24
NO1999021I1 (no) 1999-09-17
ATE406358T1 (de) 2008-09-15
ES2313730T3 (es) 2009-03-01
HUT61989A (en) 1993-03-29
JPH05507068A (ja) 1993-10-14
NL990030I2 (nl) 2000-02-01
YU48741B (sh) 1999-09-27
CA2291994C (en) 2003-10-14
NZ237936A (en) 1997-08-22
WO1991016320A1 (en) 1991-10-31
OA09679A (en) 1993-05-15
DK0526543T3 (da) 1998-08-24
DE69133604D1 (de) 2008-10-09
BG62092B1 (bg) 1999-02-26
EP0526543B1 (en) 1997-12-17
HU210717A9 (en) 1995-06-28
ES2113881T3 (es) 1998-05-16
KR0169496B1 (ko) 1999-01-15
EP0786458A2 (en) 1997-07-30
SK282950B6 (sk) 2003-01-09
HK1010191A1 (en) 1999-06-17
RU2119487C1 (ru) 1998-09-27
FI105478B (fi) 2000-08-31
NO302751B1 (no) 1998-04-20
SI9110745B (en) 2001-06-30
AU7759091A (en) 1991-11-11
ATE161253T1 (de) 1998-01-15
NL990030I1 (nl) 1999-12-01
LU90468I2 (fr) 2000-01-03
AU7533891A (en) 1991-12-12
PL166918B1 (pl) 1995-07-31
US5648379A (en) 1997-07-15
AP249A (en) 1993-03-17
CS114591A3 (en) 1991-12-17
AP9100253A0 (en) 1991-04-30
EP0526543A4 (en) 1993-04-21
DE69128469T2 (de) 1998-06-04
EP0786458A3 (en) 1999-10-13
YU74591A (sh) 1994-06-24
SG43170A1 (en) 1997-10-17
SI9110745A (en) 1997-04-30
CA2081356C (en) 2000-02-22
IE911372A1 (en) 1991-11-06
CY2186B1 (en) 2002-11-08
JP2944750B2 (ja) 1999-09-06
CN1150020A (zh) 1997-05-21
CN1184108A (zh) 1998-06-10
DE19975068I2 (de) 2002-10-10
IE980526A1 (en) 2003-10-15
FI20001231L (fi) 2000-05-23
CN1036849C (zh) 1997-12-31
NO974670L (no) 1992-12-18
EP0786458B1 (en) 2008-08-27
FI924790L (fi) 1992-10-22
CN1057260A (zh) 1991-12-25
DE69128469D1 (de) 1998-01-29
CA2081356A1 (en) 1991-10-25
PL167630B1 (pl) 1995-10-31
CZ288492B6 (en) 2001-06-13
HU9203180D0 (en) 1992-12-28
HU219355B (en) 2001-03-28

Similar Documents

Publication Publication Date Title
UA41252C2 (uk) Похідні та аналоги 2-дезокси-2,3-дидегідро-n-ацетилнеурамінової кислоти, спосіб їх одержання, фармацевтична композиція, спосіб лікування вірусних інфекцій
Wernig et al. Laufband therapy based on ‘rules of spinal locomotion’is effective in spinal cord injured persons
Hesse Treadmill training with partial body weight support after stroke: a review
CN106109175A (zh) 一种外骨骼式膝关节与踝关节康复装置
Cheng et al. Comparison of exoskeleton robots and end-effector robots on training methods and gait biomechanics
Solopova et al. Neurorehabilitation of patients with cerebral palsy
UA41288C2 (uk) Пептиди, які мають органозахисну активність, та фармакологічно активна композиція
UA41878C2 (uk) Поршневе кільце сауніна
RU2797372C1 (ru) Способ восстановления функции ходьбы и равновесия в остром периоде ишемического инсульта
RU2371211C1 (ru) Способ динамической электронейростимуляции при травмах опорно-двигательного аппарата
CN213666640U (zh) 一种骨科护理按摩康复器
RU2192838C2 (ru) Мобилизационное уравновешивание позвоночника
RU93042323A (ru) Способ реабилитационного лечения неврологических проявлений остеохондроза позвоночника
RU2098073C1 (ru) Способ лечения детских церебральных параличей
SU1109177A1 (ru) Способ лечени центральных сенсомоторных нарушений
SU889007A1 (ru) Способ реабилитации работоспособности мышц организма
RU2125863C1 (ru) Способ коррекции фигуры
SU1117046A1 (ru) Способ функционального лечени контрактур суставов конечностей
SU1251916A1 (ru) Способ электростимул ции нейромышечного комплекса у больных с двигательным церебральным дефектом
RU2167679C1 (ru) Способ лечения болевого синдрома при дисфункции височно-нижнечелюстного сустава
RU2647830C1 (ru) Способ восстановительного лечения посттравматической контрактуры голеностопного сустава после переломов костей голени
RU2243759C1 (ru) Вибрационное устройство для вытяжения
RU2107518C1 (ru) Способ нормализации движений у детей с церебральными параличами
SU942748A1 (ru) Способ реабилитации бронхолегочных больных
SU1438799A1 (ru) Способ лечени спастических форм детского церебрального паралича